Showing results (331-340 of 422) with videos related to

Sort By:
Pageof 43
Plos One|March 27, 2019
CemOrange2 fusions facilitate multifluorophore subcellular imaging in C. elegansBrian J Thomas, Ira E Wight, Wendy Y Y Chou, et al.
Cell|September 25, 2007
An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injuryCliff J Luke, Stephen C Pak, Yuko S Askew, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical TrialsJ-D Fumet, M Roulleaux Dugage, F-X Danlos, et al.
British Journal of Cancer|November 8, 2017
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancerStephanie Markovina, Songyan Wang, Lauren E Henke, et al.
The Journal of Clinical Investigation|June 6, 2023
SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine productionLiyun Chen, Victoria Shi, Songyan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 27, 2022
Lipid kinase PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseasesWenqiang Song, J Luke Postoak, Guan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial CarcinomaDavid H Aggen, Meredith McKean, Jean H Hoffman-Censits, et al.
ESMO Open|February 6, 2024
Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumorsB Perez, R Aljumaily, T U Marron, et al.
Cell Reports|November 11, 2023
Staphylococcus aureus α-toxin impairs early neutrophil localization via electrogenic disruption of store-operated calcium entryFan Yang, Mingyi Suo, Homayemem Weli, et al.
Molecular Cancer Therapeutics|February 8, 2020
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071Sophie Piperno-Neumann, James Larkin, Richard D Carvajal, et al.
Pageof 43